BRIEF published on 03/27/2025 at 19:17, 6 days 5 hours ago Advicenne Reports Solid Growth and Future Plans for 2025 Cash Flow Improvement 2025 Outlook Advicenne Financial Results Sibnayal Sales Growth ADV7103 Regulatory Progress
PRESS RELEASE published on 03/27/2025 at 19:12, 6 days 5 hours ago Inside Information / News release on accounts, results Advicenne reports successful commercial performance of Sibnayal® in Europe, with total product sales up 9.4% to €4.9m. Major strides in US development with NDA filing expected in Q3 2025 Financial Results Advicenne Commercial Performance Sibnayal US Development
BRIEF published on 10/01/2024 at 07:05, 6 months 1 day ago Advicenne Advances in US with Positive FDA Reviews for ADV7103 FDA ADV7103 ATRd Advicenna Cystinuria
PRESS RELEASE published on 10/01/2024 at 07:00, 6 months 1 day ago Inside Information / Other news releases Advicenne achieves major milestones in the US with positive FDA opinions on ADV7103, accelerating partnership outlook for commercialization, preparing for clinical development in cystinuria, and seeking commercial partners Commercialization Advicenne ADV7103 Cystinuria FDA Opinions
BRIEF published on 05/15/2024 at 09:07, 10 months 18 days ago Advicenne Shareholders Approve Board-Supported Resolutions at General Meeting Euronext Growth Paris Pharmaceutical Industry General Meeting Advicenne Rare Renal Diseases
PRESS RELEASE published on 05/15/2024 at 09:02, 10 months 18 days ago Inside Information / Other news releases Advicenne's Board of Directors' resolutions approved at the Combined General Meeting. Shareholders support all resolutions including financial statements and delegations Board Of Directors Shareholders Financial Statements Combined General Meeting Advicenne
BRIEF published on 05/15/2024 at 08:06, 10 months 18 days ago Advicenne launches a share buyback program Share Buyback Euronext Growth Financial Market Advicenne Kidney Diseases
Published on 04/02/2025 at 23:35, 56 minutes ago Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 4 hours 31 minutes ago Network-1 Announces Acquisition of Patent Portfolio
Published on 04/02/2025 at 15:00, 9 hours 31 minutes ago Doubleview Gold Corp 2025 Exploration Program
Published on 04/02/2025 at 14:00, 10 hours 31 minutes ago Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Published on 04/02/2025 at 20:20, 4 hours 10 minutes ago EQS-Adhoc: Siemens Aktiengesellschaft: Siemens acquires Dotmatics to extend AI-powered software portfolio to Life Sciences
Published on 04/02/2025 at 20:01, 4 hours 30 minutes ago Annual General Meeting of Deutsche Konsum REIT-AG successfully held
Published on 04/02/2025 at 20:01, 4 hours 30 minutes ago Travis Perkins: Publication of the Annual Report and Accounts 2024
Published on 04/02/2025 at 19:40, 4 hours 50 minutes ago LION E-Mobility AG starts successfully into the new 2025 financial year – Challenging market environment impacts 2024
Published on 04/02/2025 at 19:13, 5 hours 18 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/02/2025 at 17:45, 6 hours 46 minutes ago Aéroports de Paris SA - Voting rights as of 31 March 2025
Published on 04/02/2025 at 17:45, 6 hours 46 minutes ago Availability of the Pre-Q1 2025 Sales Communication
Published on 04/02/2025 at 17:45, 6 hours 46 minutes ago Information concerning the total number of voting rights and shares 2025 03 31
Published on 04/01/2025 at 17:45, 1 day 6 hours ago Covivio - Information on total number of voting rights and share capital
